The Center for Tobacco Control Research and Education at the University of California, San Francisco, "serves as a focal point for a broad range of research, education, and public service activities for 46 faculty in 11 departments and all 4 schools at UCSF, as well as colleagues at UC Berkeley and UC Merced." [1] It is part of the UCSF Cardiovascular Research Institute. The Center's director and principal investigator is Stanton Glantz, a Professor of Medicine in the Division of Cardiology at UCSF. [2]
In 2013, the Center received a five-year, $20 million grant from the new Tobacco Centers of Regulatory Science (TCORS) program under the US Food and Drug Administration (FDA), one of 14 US institutions funded to develop a science-based approach to tobacco regulation. [2]
The University of California, San Francisco (UCSF) is a public land-grant medical school in San Francisco, California. It is part of the University of California system and is dedicated entirely to health science and life science. It conducts research and teaching in medical and biological sciences.
The University of California (UC) is a public land-grant research university system in the U.S. state of California. The system is composed of its ten campuses at Berkeley, Davis, Irvine, Los Angeles, Merced, Riverside, San Diego, San Francisco, Santa Barbara, and Santa Cruz, along with numerous research centers and academic abroad centers. The system is the state's land-grant university. Major publications generally rank most UC campuses as being among the best universities in the world. Six of the campuses, Berkeley, Davis, Irvine, Los Angeles, Santa Barbara, and San Diego are considered Public Ivies, making California the state with the most universities in the nation to hold the title. UC campuses have large numbers of distinguished faculty in almost every academic discipline, with UC faculty and researchers having won 71 Nobel Prizes as of 2021.
The University of California College of the Law, San Francisco, UC Law SF, or UC Law is a public law school in San Francisco, California. Founded in 1878 by Serranus Clinton Hastings, UC Law SF was the first law school of the University of California as well as one of the first law schools established in California and the Western United States. Although part of the University of California, UC Law SF is not directly governed by the Regents of the University of California. UC Law SF is also one of the few prominent university-affiliated law schools in the United States that does not share a campus with the university's undergraduates or other postgraduate programs.
The California Institute for Regenerative Medicine (CIRM) was created in 2004 after 59% of California voters approved California Proposition 71: the Research and Cures Initiative, which allocated $3 billion to fund stem cell research in California.
John Michael Bishop is an American immunologist and microbiologist who shared the 1989 Nobel Prize in Physiology or Medicine with Harold E. Varmus and was co-winner of 1984 Alfred P. Sloan Prize. He serves as an active faculty member at the University of California, San Francisco (UCSF), where he also served as chancellor from 1998 to 2009.
David Aaron Kessler is an American pediatrician, attorney, author, and administrator serving as Chief Science Officer of the White House COVID-19 Response Team since 2021. Kessler was the commissioner of the Food and Drug Administration (FDA) from November 8, 1990, to February 28, 1997. He co-chaired the Biden-Harris transition’s COVID-19 Advisory Board from November 2020 to January 2021 and was the head of Operation Warp Speed, the U.S. government program to accelerate the development of COVID-19 vaccines and other treatments, from January to February 2021.
The University of California, San Francisco Medical Center is a research and teaching hospital in San Francisco, California and is the medical center of the University of California, San Francisco. It is affiliated with the UCSF School of Medicine. In 2022–23, it was ranked as the 12th-best overall hospital in the United States and one of the top three hospital in California by U.S. News & World Report.
The University of California, Berkeley School of Public Health, also called Berkeley Public Health, is one of fourteen schools and colleges at the University of California, Berkeley. The School of Public Health is consistently rated alongside the best in the nation, with recent rankings placing its doctoral programs in Epidemiology, Biostatistics, Environmental Health Sciences, and Health Policy among the top in their fields, The school is ranked 8th in the country by U.S. News & World Report. Established in 1943, it was the first school of public health west of the Mississippi River. The school is currently accredited by the Council on Education for Public Health.
Stanton Arnold Glantz is an American professor, author, and tobacco control activist. Glantz is a faculty member at the University of California, San Francisco (UCSF) School of Medicine, where he is a Professor of Medicine (retired) in the Division of Cardiology, the American Legacy Foundation Distinguished Professor of Tobacco Control, and former director of the Center for Tobacco Control Research and Education. Glantz's research focused on the health effects of tobacco smoking.
Rutherford + Chekene is a structural and geotechnical engineering firm in California specializing in new design and retrofit of structures for clients in sectors that include healthcare, higher education, corporate, research and development, art and education, and technology.
The California Institute for Quantitative Biosciences (QB3) is a nonprofit research and technology commercialization institute affiliated with three University of California campuses in the San Francisco Bay Area: Berkeley, San Francisco, and Santa Cruz. QB3's domain is the quantitative biosciences: areas of biology in which advances are chiefly made by scientists applying techniques from physics, chemistry, engineering, and computer science.
Sue Desmond-Hellmann is an American oncologist and biotechnology leader who served as the Chief Executive Officer of the Bill & Melinda Gates Foundation from 2014–2020. She was previously Chancellor of the University of California, San Francisco (UCSF), the first woman to hold the position, and Arthur and Toni Rembe Rock Distinguished Professor, and before that president of product development at Genentech, where she played a role in the development of the first gene-targeted cancer drugs, Avastin and Herceptin.
Lisa Anne Bero, born 1958, is an academic who originally trained in pharmacology and went on to a career studying research integrity and how clinical and basic sciences are translated into clinical practice and health policy. She is Chair of Medicines Use and Health Outcomes at the University of Sydney. From 1991 until 2014, she was Professor in the Department of Clinical Pharmacy and in the Institute of Health Policy Studies at the University of California, San Francisco (UCSF), and is currently an adjunct professor there. She is also Chair of the World Health Organization (WHO) Essential Medicines Committee, Director of the WHO Collaborating Centre for Pharmaceutical Research and Science Policy, and Co-Chair of the Cochrane Collaboration. Bero has received multiple awards for her extensive mentoring of high school students to junior faculty.
The UCSF Library is the library of the University of California, San Francisco. It is one of the world's foremost libraries in the health sciences.
The UCSF School of Medicine is the medical school of the University of California, San Francisco and is located at the base of Mount Sutro on the Parnassus Heights campus in San Francisco, California. Founded in 1864 by Hugh Toland, it is the oldest medical school in California and in the western United States. U.S. News & World Report ranked the school third in research training and second in primary care training; it is the only medical school in the nation to rank among the top three in both categories. Six members of the UCSF faculty have received the Nobel Prize in Physiology or Medicine and five have received the National Medal of Science.
Thomas J. Coates is the Director of the multi-campus University of California Global Health Institute, a UC-wide initiative established to improve health and reduce the burden of disease throughout the world. He is Professor Emeritus at the UCLA David Geffen School of Medicine and Founding Director of the UCLA Center for World Health, a joint initiative of the David Geffen School of Medicine at UCLA and UCLA Health, He has conducted extensive research in the realm of HIV and is the Michael and Sue Steinberg Endowed Professor of Global AIDS Research within the Division of Infectious Diseases at UCLA and Distinguished Professor of Medicine. Health-related behavior is of particular interest to Coates. Throughout his career as a health expert, his theory-based research has been focused on interventions aimed at reducing risks and threats to health
Ruth E. Malone is an American tobacco control researcher and policy analyst. She is professor in the Department of Social and Behavioral Sciences at the University of California, San Francisco School of Nursing. She has been the editor-in-chief of Tobacco Control since 2009. She holds the Mary Harms/Nursing Alumni Endowed Chair.
John C. Greene was an American dentist and public health administrator. He was a rear admiral in the U.S. Public Health Service Commissioned Corps, and served as the Deputy Surgeon General of the United States under President Carter from 1978 to 1981. He was the Acting Surgeon General from January to May 1981 under Ronald Reagan. He was the highest ranking non-physician public health officer in the history of the U.S. government.
UCSF Helen Diller Family Comprehensive Cancer Center is an NCI-designated Cancer Center, affiliated with the UCSF School of Medicine and the UCSF Medical Center. It is one of 69 cancer research institutions in the United States supported by the National Cancer Institute, and one of three in Northern California. The HDFCCC integrates basic and clinical science, patient care, and population science to address prevention and early detection of cancer as well as the quality of life following diagnosis and treatment.
Kathleen M. Giacomini is a professor of bioengineering and therapeutic sciences at the University of California, San Francisco. Her work focuses on how genetics affects the efficacy of drugs. She is also the co-Director UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation for the department of Bioengineering at the University of California, San Francisco.